SimcoDerm Clinical Trials

09/23/2025

Alopecia Areata Study --No Placebo--

(57 Weeks)
________________________________

Adolescents and adults aged 18 and above with AA may qualify to participate.
Inclusion Criteria
• have a clinical diagnosis of AA with no other cause of hair loss
• have ≥ 50% hair loss of the scalp
• have current episode of hair loss less than 10 years
Participant Information
• Participate and receive study treatment at no cost
• Regular visits with study doctors who specialise in treating alopecia areata (10 visits)
• Will receive an investigative oral treatment (study drug)
• Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
• 57 week
SimcoDerm Clinical Research is one of Canada’s most trusted dermatology trial sites, known for rapid, reliable patient recruitment and high-quality data. We’re frequently among the top enrolling sites in global trials and have been the first in Canada to launch new therapies.

Visit https://simcoderm.com/b7981094-for-alopecia/ or call (289)-763-8666

09/19/2025

🎶 What’s it like to join a clinical trial? 🎶
Turns out, it’s not as complicated as you might think.

Here are the 4 main things you’ll do 👇

1️⃣ 🧑‍⚕️ Medical checks → routine evaluations to keep you safe.
2️⃣ 💊 Study medication → take the trial drug under expert supervision.
3️⃣ 📝 Reporting → share how you feel, including any side effects.
4️⃣ 📚 Learning → get clear info on the trial and what to expect.

✨ Simply put: some visits are for tests, some are for medication, and some are just for sharing your experience.

💡 Pro tip: bring a book, music, or something fun — sometimes there’s a little waiting involved. 🎧📖

👉 Want to learn more? Tap here:
🔗 https://simcoderm.com/what-are-clinical-trials/

09/17/2025

Maybe this helps someone? It looks like a quality article!

Questions about psoriatic disease and weight loss medications?

On this episode of join dermatologist Dr. Erin Boh and patient advocate Brian Lehrschall as they talk about weight, psoriasis, psoriatic arthritis, and what to know about weight management medications.

👉 Check out this episode at https://www.psoriasis.org/watch-and-listen/finding-my-path-to-managing-psoriatic-disease-and-excess-weight-lilly/ or anywhere you listen to podcasts.

09/10/2025

September is Alopecia Awareness Month.💙

Alopecia is an autoimmune condition that causes hair loss sometimes in patches, sometimes across the whole scalp or body. While it doesn’t cause physical pain, it often leads to feelings of shame, anxiety, and self-consciousness.

At SimcoDerm, we’re standing with the alopecia community this month. Together, we can break the stigma, build understanding, and support research that leads to better treatments and, one day, a cure.

📸 Here’s our team showing support for patients and families living with alopecia.

09/05/2025

👀 What’s next for HS treatments?
We’ve scanned the latest reports so you don’t have to. Here’s what’s happening in clinical trials for HS medications this quarter.
Full update: https://simcoderm.com/2025/09/2025-q2-hs-research-update/

09/04/2025

Society spends a lot of time talking about current issues. But it’s easy to forget that billions of people live every day with substantial levels of pain. That’s why, in September, we raise awareness of pain.

💡 Chronic pain is more than “just discomfort”:
• 1 in 3 seniors in Canada lives with it.
• Up to 1 in 3 kids do, too.
• It costs our country as much as $60 billion every year.

For many — especially women, veterans, and Indigenous Peoples — pain is not only physical. It’s deeply tied to emotional health and social inequality.

✨ Raising awareness means reminding society that pain is real, life-altering, and worthy of action.
👉 Share this message. Together, we can break the silence around pain. 💙.

08/28/2025

Progress

Systematic review: Hidradenitis suppurativa (HS) is linked to significant psychological comorbidities, including disordered eating behaviors. https://ja.ma/4oVXoD2

08/19/2025

A useful perspective on treating atopic dermatitis.

🎥Balancing efficacy and safety in atopic dermatitis treatment: Discover how clinicians navigate JAK inhibitor therapy, from patient selection to risk management: https://hubs.li/Q03DgqCC0

08/19/2025

Sometimes medical care doesn't offer a great solution to skin disease. A severe case of eczema, for example, can continue to cause stress and burden despite the best efforts of dermatologists.

That's why we run clinical trials. It is the scientific way to determine the safety and effectiveness of new treatments. If you want to help us research potential new therapies for skin conditions call us at (289)763-8666 or visit www.simcoderm.com/clinicaltrials.

08/05/2025

"New study in the Journal of American Academy of Dermatology explores tunnel-targeted antimicrobial gel for HS treatment"
It's refreshing to see motion in the world of HS treatment. Looking forward to further study!

💜 New study in Journal of the American Academy of Dermatology (JAAD) explores tunnel-targeted antimicrobial gel for HS treatment bit.ly/HSFnews

🙌 Shout out to University of Miami Miller School of Medicine researchers including HSF President, Dr. Hadar Lev-Tov, for this work that offers new insights into localized therapies for HS.

07/28/2025

🎥IL-17 Inhibitors can make a significant impact for patients with psoriasis. Hear from top dermatologists as they break down efficacy, safety, and real-world application. Watch here: https://hubs.li/Q03z1lz-0